Modified proteins as possible signals in the acute phase response.
Koj
A
A
Institute of Molecular Biology, Jagiellonian University, Kraków, Poland.
Guzdek
A
A
D000210:Acute-Phase Reaction; D001798:Blood Proteins / Q000737:chemistry*; D003176:Complement C3 / Q000096:biosynthesis; D005340:Fibrinogen / Q000096:biosynthesis; D006801:Humans; D066298:In Vitro Techniques; D007375:Interleukin-1 / Q000378:metabolism*; D015850:Interleukin-6 / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008264:Macrophages / Q000378:metabolism*; D009000:Monocytes / Q000378:metabolism*; D017239:Paclitaxel / Q000494:pharmacology; D010587:Phagocytosis / Q000187:drug effects; D011112:Polymyxin B / Q000494:pharmacology; D015398:Signal Transduction
D001798:Blood Proteins; D003176:Complement C3; D007375:Interleukin-1; D015850:Interleukin-6; D008070:Lipopolysaccharides; D005340:Fibrinogen; D011112:Polymyxin B; D017239:Paclitaxel